Acceleron Pharma Q1 FY19: revenue $2.8M

Key figures from this report

These are the numbers Acceleron Pharma reported for Q1 FY19, the quarter ended Mar 31, 2019, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Revenue$2.8MNo year-earlier figure tagged10-Q income statement, on EDGAR
2. Net income−$38.1MNo year-earlier figure tagged10-Q income statement, on EDGAR
3. Cash and cash equivalents$214.5MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
4. Cash from operations−$26.3MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR